Volume 19, Number 5—May 2013
Research
Changes in Severity of Influenza A(H1N1)pdm09 Infection from Pandemic to First Postpandemic Season, Germany
Table 4
Demographic and clinical characteristics of patients infected with influenza A(H1N1)pdm09 who died, Germany, 2010–11*
| Patient no. | Age, y/sex | Underlying condition | Bacterial coinfection | Pneumonia type (per chest radiograph) | Complications (other than pneumonia) | Antiviral therapy | Mechanical ventilation | Length of hospital stay, d |
|---|---|---|---|---|---|---|---|---|
| 1 | 28/M | Lliver/kidney transplant | No | Bipulmonary | Renal and liver failure, SIRS | Yes | Yes | 13 |
| 2 | 75/F | CHD, COPD, post breast cancer | No | Unilobar | Myocardial infarction | Yes | Yes | 37 |
| 3 | 68/M | Multiple myeloma | No | Bipulmonary | Pneumothorax | Yes | Yes, + ECMO | 56 |
| 4 | 71/M | Multiple myeloma | No | Bipulmonary | Yes | Yes, + ECMO | 19 | |
| 5 | 18/F | None | No | No | Myocarditis | No | Yes | 2 |
| 6 | 57/F | Multiple myeloma | Enterococcus faecium | Bipulmonary | RSV coinfection | Yes | Yes, + NO | 12 |
| 7 | 52/F | Multiple myeloma | No | Bipulmonary | Yes | Yes, + NO | 17 | |
| 8 | 85/F | Parkinson disease, epilepsy | No | Bipulmonary | Myocardial infarction | No | Yes, + NO | 4 |
| 9 | 65/F | Esophageal carcinoma | No | Bipulmonary | ARDS | Yes | Yes, + NO, + ECMO | 52 |
| 10 | 61/F | PBC, chronic hepatitis B, diabetes, COPD | Enterococcus cloacae, Achromobacter sp. | Bipulmonary | Renal and liver failure, sepsis, lung edema | Yes | Yes, + NO | 53 |
| 11 | 45/F | Acute leptospirosis | E. faecium, Leptospira sp. | Bipulmonary | Renal and liver failure | Yes | Yes | 13 |
| 12 | 49/M | Colitis ulcerosa | Escherichia coli | Bipulmonary | Perforation of colon, hemorrhagic shock, lung edema | Yes | Yes, + NO, + ECMO | 8 |
| 13 | 61/F | CHD, CKD | Klebsiella pneumoniae | Bipulmonary | Septic shock | Yes | Yes, + NO | 28 |
| 14 | 53/F | Liver cirrhosis | E. faecium | Bipulmonary | Renal and liver failure, septic shock, CMV reactivation, aspergillosis | Yes | Yes | 43 |
| 15 | 52/M | Multiple myeloma, post allogenic transplant | E. faecium | Bipulmonary | GvHD 4, cerebral hemorrhage, CMV reactivation, progressive myeloma | Yes | Yes | 46 |
*SIRS, systemic inflammatory response syndrome; CHD, congestive heart disease; COPD, chronic obstructive pulmonary disease; ECMO, extracorporeal membrane oxygenation; RSV, respiratory syncytial virus; NO, nitric oxide; ARDS, acute respiratory distress syndrome; PBC, primary biliary cirrhosis; CKD, chronic kidney disease; CMV, cytomegalovirus; GvHD, graft versus host disease.
1These authors contributed equally to this article.
Page created: April 23, 2013
Page updated: April 23, 2013
Page reviewed: April 23, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.